#pharmacogenetic testing

[ehlers-danloscircus]

Look what got here today!

[ehlers-danloscircus]

My genetic tests came back but we haven't had power since late Wednesday due to the huge storm in this area. They estimated tomorrow but we have a electrical crew out here supervising tree removal from my neighbors house that say there's a whole pole down in the area and that's what's holding up the show sooooo....

Managed to charge my phone of the last of the back battery for my pc and I'm just trying to save as my phone battery as possible. But I might be able to sneak a peak at the results.

[misseighties]

My psychiatrist asked me to do pharmacogenetic testing because I'm having issues with meds (like I gained 8 kilos while on amphetamines)

Pharmacogenetic testing is a DNA exam that tests how your liver metabolize a bunch of different drugs and the you get a report telling you which drugs will work as expected and which are likely to not work or have side effects etc

It's pretty cool for a science nerd like myself

But I think the best part is it will test for THC lol. Will I finally learn why I had such a bad time with weed in college? Too bad they don't include cocaine

Though they do include amphetamines and opioids, which should be interesting. Once, a doctor offered me tramadol for a fibromyalgia crisis and it had NO effect whatsoever

[pinkmedicalonline]

How Genetic Testing Shapes Breast Cancer Treatment Plans

With the rise of personalized medicine, genetic testing has become a powerful tool in assessing and guiding breast cancer treatment plans. By revealing a person's unique genetics and a tumor's characteristics, these tests empower doctors to craft targeted therapies and make informed surgical decisions for better patient outcomes. Whether a woman is recently diagnosed with breast cancer or has a strong family history of the condition, genetic testing for women has become a vital part of the treatment conversation. What is genetic testing in breast cancer? Genetic testing for breast cancer falls into two main categories: germline testing and tumor genomic testing. Germline testing identifies inherited mutations such as BRCA1 and BRCA2, which are present in every cell of the body. In contrast, tumor genomic testing analyzes the specific genetics of the cancer itself. Both types of testing provide valuable insights into treating a patient's cancer effectively. When someone tests positive for an inherited mutation, doctors can modify treatment plans to decrease the risk of future cancer development. Meanwhile, tumor testing helps determine which medications a cancer is most likely to respond to, enabling truly personalized treatment approaches. Treatment guided by genetics One of the significant advantages of genetic testing is its role in personalized therapy. BRCA1 and BRCA2 pathogenic variants are clinically relevant for treatment selection in breast cancer because they confer sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors. This testing helps healthcare providers understand how genetics respond to specific medications, potentially preventing negative reactions and treatment failures. Olaparib and talazoparib are now approved for the treatment of metastatic germline BRCA1 or BRCA2 pathogenic or likely pathogenic variant–associated breast cancer. Recent breakthrough research shows that patients with high-risk, BRCA-positive breast cancer who received olaparib after standard treatment continued to have better survival outcomes than those who received placebo after a median follow-up of 6.1 years. Furthermore, genetic testing helps determine whether a patient will benefit from chemotherapy. For patients in early stages of cancer, these tests can help avoid unnecessary chemotherapy while ensuring timely, appropriate treatment when needed. Guiding surgical decisions Genetic testing results significantly influence surgical options. BRCA1/2 mutation testing should be offered to all newly diagnosed patients with breast cancer ≤65 years and select patients >65 years based on personal history, family history, ancestry, or eligibility for poly(ADP-ribose) polymerase (PARP) inhibitor therapy. Women with BRCA mutations may consider risk-reducing surgeries, such as bilateral mastectomy or removal of ovaries and fallopian tubes, to lower their cancer risk. Others may opt for enhanced surveillance or preventative medications, depending on their genetic findings and personal preferences. Current treatment advances The field of pharmacogenetic testing and targeted therapy continues to evolve rapidly. Clinical Efficacy: Olaparib and talazoparib are more effective than chemotherapy in treating BRCA-mutated breast cancer, improving survival rates in both early and metastatic stages according to recent clinical trials. The PARTNER trial has found a new way to treat inherited breast cancers linked to BRCA mutations, and reported 100% survival by combining olaparib with chemotherapy in a specific timing sequence before surgery. Additionally, researchers are exploring combination therapies, including PARP inhibitors with immunotherapy, to enhance treatment effectiveness and overcome potential resistance mechanisms. Who should consider genetic testing? Current guidelines recommend genetic testing for individuals with:

Personal history of breast cancer diagnosed at age 65 or younger

Strong family history of breast, ovarian, or related cancers

Ashkenazi Jewish ancestry

Male breast cancer in the family

Multiple cancers in the same individual or family

About 1 in 300 people to 1 in 800 people carry a BRCA1 or BRCA2 mutation, and early identification can significantly impact treatment decisions and family planning. Looking ahead The integration of genetic testing into breast cancer care represents a fundamental shift toward precision medicine. As our understanding of genetic factors continues to expand, more targeted therapies are becoming available, offering hope for improved outcomes and quality of life for patients with hereditary breast cancer syndromes. Early detection through genetic testing, combined with advanced targeted therapies, continues to transform the landscape of breast cancer treatment, providing patients and their families with more options and better outcomes than ever before. About Pink Medical: Pink Medical specializes in comprehensive breast health services, including cardiovascular genetic testing and advanced diagnostic imaging. Our all-female team includes healthcare providers with extensive experience in breast imaging and testing services. We provide innovative painless high quality mammogram technology combined with comprehensive ultrasound and genetic testing to personalize your care, protect your health and safeguard your wellbeing. For more information, visit https://pinkmedicalny.com/ Original source: http://bit.ly/4lW6yxn

[sonicgenetics]

Top 5 Benefits of Pharmacogenetic Testing for Personalised Healthcare

In modern medicine, there is a growing shift towards personalised healthcare, where treatments are tailored to an individual’s unique biological makeup. One of the most promising advancements in this field is pharmacogenetic testing, which analyses a person’s genetic profile to determine how they will respond to specific medications. This innovative approach helps healthcare providers make more precise and effective treatment decisions, improving patient outcomes and minimising risks.

In this article, we explore the top five benefits of pharmacogenetic testing and how it is revolutionising personalised healthcare.

1. Improved Medication Effectiveness

Not all medications work the same way for everyone. Some people may experience significant benefits, while others may find little to no relief. This variation occurs because individuals metabolise drugs differently based on their genetic makeup.

Pharmacogenetic testing helps identify which medications are most likely to work effectively for a specific individual. By understanding how a person's genes influence drug absorption, metabolism, and response, doctors can prescribe medications that will be the most beneficial, reducing the need for trial-and-error prescribing.

2. Reduced Risk of Adverse Drug Reactions

Adverse drug reactions (ADRs) are a serious concern in healthcare, often leading to hospitalisations and complications. A medication that works well for one person might cause severe side effects in another due to genetic differences in how the body processes the drug.

Pharmacogenetic testing allows healthcare professionals to identify potential risks before prescribing medication. By understanding how an individual metabolises a drug, doctors can adjust dosages or select alternative medications that minimise harmful side effects. This approach enhances patient safety and reduces healthcare costs associated with treating ADRs.

3. More Accurate Dosage Adjustments

Finding the right dosage for a medication can be challenging, as standard dosing guidelines do not account for individual genetic differences. Some people metabolise drugs too quickly, making standard doses ineffective, while others process them too slowly, increasing the risk of overdose or side effects.

With pharmacogenetic testing, healthcare providers can determine the optimal dosage based on an individual’s genetic profile. This personalised approach ensures that patients receive the right amount of medication to achieve the best therapeutic effect without unnecessary risks.

4. Enhanced Treatment for Chronic Conditions

Patients with chronic conditions such as heart disease, depression, diabetes, and chronic pain often require long-term medication management. However, finding the right medication and dosage can be a lengthy process of trial and error.

Pharmacogenetic testing streamlines this process by providing valuable insights into how a person’s body responds to different medications. For example, in mental health treatment, antidepressants and antipsychotics can have highly variable effects among individuals. Genetic testing helps determine which medications are most suitable, reducing the frustration and time associated with finding an effective treatment.

For patients with cardiovascular conditions, pharmacogenetics can guide the selection of blood thinners, cholesterol-lowering drugs, and other medications, ensuring optimal efficacy and reducing the risk of complications.

5. Cost Savings for Patients and Healthcare Systems

Healthcare costs can escalate when patients experience ineffective treatments, adverse drug reactions, or prolonged hospital stays due to medication-related complications. Pharmacogenetic testing helps reduce these costs by ensuring that patients receive the right medication from the start.

By avoiding ineffective prescriptions, reducing hospital admissions related to ADRs, and minimising trial-and-error treatments, pharmacogenetic testing leads to significant cost savings for both patients and healthcare systems. In the long run, this approach improves the efficiency of medical treatments and enhances overall healthcare quality.

The Future of Pharmacogenetic Testing in Personalised Healthcare

As research in pharmacogenetics continues to advance, the integration of genetic testing into standard medical practice is expected to become more widespread. With more accessible and affordable testing options, more patients will benefit from personalised medication plans tailored to their genetic profiles.

In the future, pharmacogenetics could become a routine part of medical check-ups, helping individuals understand their medication responses before they even need treatment. This proactive approach to healthcare has the potential to improve patient safety, treatment outcomes, and overall well-being.

Pharmacogenetic testing is a game-changer in personalised healthcare, offering a precise and effective way to match medications to an individual's genetic profile. By improving medication effectiveness, reducing adverse drug reactions, optimising dosages, enhancing treatment for chronic conditions, and lowering healthcare costs, this innovative approach is transforming the way medicine is practiced.

As pharmacogenetic testing continues to evolve, it has the potential to become a standard tool for improving patient care, ensuring safer and more effective treatments for people around the world.

[4uhealth]

Comprehensive Full Panel STD Testing: What You Need to Know

In today's world, sexual health is an essential aspect of overall well-being. Regular testing for sexually transmitted diseases (STDs) is crucial in maintaining sexual health and preventing the spread of infections. One effective approach to this is through comprehensive full panel std testing near me. But what exactly does this entail, and where can you find reliable testing near you? Additionally, with advancements in medical science, pharmacogenetic testing has become a significant tool in personalized medicine. Let's explore these topics in detail.

[ehlers-danloscircus]

So our power came back on Friday afternoon, I was so exhausted though that after I looked at my DNA test results I just crashed and didn’t really do much else over the weekend. Basically, it looks like I have 6 or 7 different genes that might have an impact on how I’m metabolizing different medications. I will be talking to my psychiatrist in 2 weeks and then I have a regular doctor appointment later in the month so I’m just waiting for them to check out the results and explain it all to me. I’m trying not to get overwhelmed by it, it’s nice to have the info but at the same time it feels overwhelming a bit to see it on paper that all my experiences with medications and especially the wellbutrin wasn’t just in my head or for no/random reason. My body just genuinely doesn’t know how to handle things in the way they were intended. *sigh* ok gotta jet, I have therapy!

[yesmyhealth]

Is the medication you're taking suiting you genetically? Get the answers with Pharmacogenetic Testing with www.yesmyhealth.com.